Evidence map›Paper›PMID 26671989›Full record

ArticleEMBO molecular medicine2016

Molecular cause and functional impact of altered synaptic lipid signaling due to a prg-1 gene SNP.

Johannes Vogt, Jenq-Wei Yang, Arian Mobascher, Jin Cheng, Yunbo Li, Xingfeng Liu, Jan Baumgart, Carine Thalman, Sergei Kirischuk, Petr Unichenko and 21 more

Open access · goldAbstract read
In one paragraph

Article in EMBO molecular medicine, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 34 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
34citing papers in PubMed, 1 pooled it
1.8field-weighted citation impact, top 15% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

34 citing papers in PubMed, 1 synthesis or guideline pooled it, 47 citations in OpenAlex.

  1. Pooled it
  2. Review
  3. Article
  4. Article
  5. Article
  6. Article
  7. Review
  8. Article
  9. Article
  10. Article
  11. LPA1 receptors in the lateral habenula regulate negative affective states associated with alcohol withdrawal.Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology · 2023
    Article
  12. Article
  13. Article
  14. Preserving stroke penumbra by targeting lipid signalling.Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism · 2023
    Article
  15. Article
  16. Article
  17. Review
  18. Review
  19. Article
  20. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

31 authors at 6 institutions in 2 countries.

Johannes VogtInstitute for Microscopic Anatomy and Neurobiology, University Medical Center, Johannes Gutenberg-University, Mainz, Germany johannes.vogt@unimedizin-mainz.de robert.nitsch@unimedizin-mainz.de.
Jenq-Wei YangInstitute for Physiology and Pathophysiology, University Medical Center, Johannes Gutenberg-University, Mainz, Germany.
Arian MobascherDepartment of Psychiatry and Psychotherapy, University Medical Center, Johannes Gutenberg-University Mainz, Mainz, Germany.
Jin ChengInstitute for Microscopic Anatomy and Neurobiology, University Medical Center, Johannes Gutenberg-University, Mainz, Germany.
Yunbo LiInstitute for Microscopic Anatomy and Neurobiology, University Medical Center, Johannes Gutenberg-University, Mainz, Germany.
Xingfeng LiuInstitute for Microscopic Anatomy and Neurobiology, University Medical Center, Johannes Gutenberg-University, Mainz, Germany.
Jan BaumgartInstitute for Microscopic Anatomy and Neurobiology, University Medical Center, Johannes Gutenberg-University, Mainz, Germany.
Carine ThalmanInstitute for Microscopic Anatomy and Neurobiology, University Medical Center, Johannes Gutenberg-University, Mainz, Germany.
Sergei KirischukInstitute for Physiology and Pathophysiology, University Medical Center, Johannes Gutenberg-University, Mainz, Germany.
Petr UnichenkoInstitute for Physiology and Pathophysiology, University Medical Center, Johannes Gutenberg-University, Mainz, Germany.
Guilherme HortaInstitute for Microscopic Anatomy and Neurobiology, University Medical Center, Johannes Gutenberg-University, Mainz, Germany.
Konstantin RadyushkinFocus Program Translational Neuroscience (FTN), University Medical Center, Johannes Gutenberg-University, Mainz, Germany.
Albrecht StrohInstitute for Microscopic Anatomy and Neurobiology, University Medical Center, Johannes Gutenberg-University, Mainz, Germany.
Sebastian RichersInstitute for Microscopic Anatomy and Neurobiology, University Medical Center, Johannes Gutenberg-University, Mainz, Germany.
Nassim SahragardInstitute for Microscopic Anatomy and Neurobiology, University Medical Center, Johannes Gutenberg-University, Mainz, Germany.
Ute DistlerFocus Program Translational Neuroscience (FTN), University Medical Center, Johannes Gutenberg-University, Mainz, Germany Institute for Immunology, University Medical Center, Johannes Gutenberg-University Mainz, Mainz, Germany.
Stefan TenzerInstitute for Immunology, University Medical Center, Johannes Gutenberg-University Mainz, Mainz, Germany.
Lianyong QiaoInstitute for Microscopic Anatomy and Neurobiology, University Medical Center, Johannes Gutenberg-University, Mainz, Germany.
Klaus LiebDepartment of Psychiatry and Psychotherapy, University Medical Center, Johannes Gutenberg-University Mainz, Mainz, Germany.
Oliver TüscherDepartment of Psychiatry and Psychotherapy, University Medical Center, Johannes Gutenberg-University Mainz, Mainz, Germany.
Harald BinderInstitute of Medical Biostatistics, Epidemiology and Informatics, University Medical Center, Johannes Gutenberg-University Mainz, Mainz, Germany.
Nerea FerreirosInstitute of Clinical Pharmacology Goethe-University Hospital, Frankfurt am Main, Germany.
Irmgard TegederInstitute of Clinical Pharmacology Goethe-University Hospital, Frankfurt am Main, Germany.
Andrew J MorrisDivision of Cardiovascular Medicine, Gill Heart Institute, University of Kentucky, Lexington, KY, USA.
Sergiu GropaDepartment of Neurology, University Medical Center, Johannes Gutenberg-University Mainz, Mainz, Germany.
Peter NürnbergCologne Center for Genomics (CCG), University of Cologne, Cologne, Germany.
Mohammad R ToliatCologne Center for Genomics (CCG), University of Cologne, Cologne, Germany.
Georg WintererCologne Center for Genomics (CCG), University of Cologne, Cologne, Germany.
Heiko J LuhmannInstitute for Physiology and Pathophysiology, University Medical Center, Johannes Gutenberg-University, Mainz, Germany.
Jisen HuaiInstitute for Microscopic Anatomy and Neurobiology, University Medical Center, Johannes Gutenberg-University, Mainz, Germany.
Robert NitschInstitute for Microscopic Anatomy and Neurobiology, University Medical Center, Johannes Gutenberg-University, Mainz, Germany johannes.vogt@unimedizin-mainz.de robert.nitsch@unimedizin-mainz.de.
Johannes Gutenberg University Mainz · DEUniversity Medical Center of the Johannes Gutenberg University Mainz · DEUniversity of Cologne · DEGoethe University Frankfurt · DEFocus (Germany) · DEUniversity of Kentucky · US

Funding

Lipid phosphate phosphatase 3 as a novel atherosclerosis suppressorR01HL120507 · NHLBI · UNIVERSITY OF KENTUCKY · PI MORRIS, ANDREW J, SMYTH, SUSAN S. · 2015 to 2018
$2.1M
NHLBI NIH HHS R01 HL120507
6 · The paper itself

Abstract

Loss of plasticity-related gene 1 (PRG-1), which regulates synaptic phospholipid signaling, leads to hyperexcitability via increased glutamate release altering excitation/inhibition (E/I) balance in cortical networks. A recently reported SNP in prg-1 (R345T/mutPRG-1) affects ~5 million European and US citizens in a monoallelic variant. Our studies show that this mutation leads to a loss-of-PRG-1 function at the synapse due to its inability to control lysophosphatidic acid (LPA) levels via a cellular uptake mechanism which appears to depend on proper glycosylation altered by this SNP. PRG-1(+/-) mice, which are animal correlates of human PRG-1(+/mut) carriers, showed an altered cortical network function and stress-related behavioral changes indicating altered resilience against psychiatric disorders. These could be reversed by modulation of phospholipid signaling via pharmacological inhibition of the LPA-synthesizing molecule autotaxin. In line, EEG recordings in a human population-based cohort revealed an E/I balance shift in monoallelic mutPRG-1 carriers and an impaired sensory gating, which is regarded as an endophenotype of stress-related mental disorders. Intervention into bioactive lipid signaling is thus a promising strategy to interfere with glutamate-dependent symptoms in psychiatric diseases.

Indexed as

Polymorphism, Single NucleotideAnimalsElectroencephalographyEvoked PotentialsGlycosylationHEK293 CellsHumansLysophospholipase DLysophospholipidsMental DisordersMiceMice, Inbred C57BLMice, KnockoutPatch-Clamp TechniquesPhosphopeptidesPhosphoric Diester Hydrolaseslysophosphatidic acidLysophospholipase DLysophospholipidsPhosphopeptidesPhosphoric Diester HydrolasesProteoglycansserglycinVesicular Transport Proteinsbioactive phospholipidscortical networkPRG‐1psychiatric disorderssynapse

Identifiers

PMID26671989
PMCPMC4718157
OpenAlexW2223729911

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.